Natroba™ (spinosad) Topical Suspension, 0.9% for head lice1

ParaPRO first commercialized the use of spinosad in Natroba™ Topical Suspension, 0.9% for the treatment of head lice. The product received FDA approval in 2011 and has since become the most widely prescribed product for infestations.1,2 Natroba™ is also available as an Authorized Generic under the name Spinosad Topical Suspension, 0.9% to enhance access to patients and families who are afflicted with this condition.

Learn more about this proven therapy for today’s head lice infestations. Visit or for the latest evidence-based clinical data and insights from the leading scientific and medical experts.

References: 1. Natroba Prescribing Information. 2. IQVIA – National prescription market share: Head lice,8.31.19 PPO-PPW6-000